Dimensional Fund Advisors LP Eli Lilly & CO Transaction History

Dimensional Fund Advisors LP

$391 Billion
Q1 2025

A detailed history of Dimensional Fund Advisors LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 3,796,285 shares of LLY stock, worth $2.83 Billion. This represents 0.8% of its overall portfolio holdings.

Number of Shares

3,796,285

Previous 3,702,207 2.54%

Holding current value

$2.83 Billion

Previous $2.86 Billion 9.7%

% of portfolio

0.8%

Previous 0.71%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$725.72 - $929.72 $68.3 Million - $87.5 Million	94,078 Added 2.54%	3,796,285 $3.14 Billion
Q4 2024 Feb 13, 2025	BUY	$727.2 - $932.06 $34.4 Million - $44.2 Million	47,373 Added 1.3%	3,702,207 $2.86 Billion
Q3 2024 Nov 07, 2024	BUY	$772.14 - $960.02 $57 Million - $70.8 Million	73,759 Added 2.06%	3,654,834 $3.24 Billion
Q2 2024 Aug 09, 2024	BUY	$724.87 - $909.04 $124 Million - $156 Million	171,595 Added 5.03%	3,581,075 $3.24 Billion
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $8.04 Million - $10.8 Million	13,584 Added 0.4%	3,409,480 $2.65 Billion
Q4 2023 Feb 07, 2024	BUY	$525.19 - $619.13 $14.8 Million - $17.4 Million	28,104 Added 0.83%	3,395,896 $1.98 Billion
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $22.5 Million - $31.1 Million	51,826 Added 1.56%	3,367,792 $1.81 Billion
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $35.1 Million - $46.9 Million	100,101 Added 3.11%	3,315,966 $1.56 Billion
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $9.13 Million - $10.7 Million	29,401 Added 0.92%	3,215,865 $1.1 Billion
Q4 2022 Feb 09, 2023	BUY	$321.55 - $374.67 $17.6 Million - $20.6 Million	54,887 Added 1.75%	3,186,464 $1.17 Billion
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $18.2 Million - $20.7 Million	61,303 Added 2.0%	3,131,577 $1.01 Billion
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $20.3 Million - $23.9 Million	72,889 Added 2.43%	3,070,274 $995 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $2.45 Million - $3.04 Million	-10,431 Reduced 0.35%	2,997,385 $858 Million
Q4 2021 Feb 09, 2022	BUY	$224.85 - $279.04 $2.09 Million - $2.59 Million	9,290 Added 0.31%	3,007,816 $831 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $3.97 Million - $4.89 Million	-17,931 Reduced 0.59%	2,998,526 $693 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $5.11 Million - $6.61 Million	28,284 Added 0.95%	3,016,457 $692 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $4.05 Million - $5.24 Million	24,622 Added 0.83%	2,988,173 $558 Million
Q4 2020 Feb 25, 2021	BUY	$130.46 - $172.63 $387 Million - $512 Million	2,963,551 New	2,963,551 $500 Million

Others Institutions Holding LLY

# of Institutions

4,404

Shares Held

807M

Call Options Held

9.91M

Put Options Held

10.9M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Eli Lilly & CO Transaction History